Q1 2025 Progress Report on Patient Support Programs

This progress report details the current state of patient support programs (PSPs) within the pharmaceutical industry, focusing on specialty, specialty-lite, and retail sectors. It outlines the varying models of PSPs, including outsourced, insourced, and hybrid approaches, and discusses their respective pros and cons. The report emphasizes the importance of aligning organizational goals with the appropriate PSP model to enhance patient and healthcare provider experiences. Additionally, it presents insights into emerging trends in healthcare, such as direct-to-consumer (DTC) approaches and the evolving landscape of PSP vendor transitions. The document also highlights the top priorities for life sciences organizations in 2025, including staffing challenges and the need for scalable solutions. By providing this information, the report aims to empower organizations to make informed decisions regarding their investments in patient support initiatives.